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Embryonic stem cells (ESCs) are defined by two essential features—pluripotency and self-renewal—whose
balance requires the concerted action of signal transduction pathways, transcription factor networks, and
epigenetic regulators. Recent findings have implicated the NuRD chromatin remodeling complex in the
sophisticated choreography of ESC regulatory pathways.Embryonic stem cells (ESCs) face a special regulatory challenge
essential to their unique biological properties. These cells must
maintain the capacity to self-renew, while having the potential,
upon receiving appropriate physiologic cues, to differentiate
along diverse lineages. These properties imply an ability to
maintain expression of genes integral to the pluripotency
program in such a manner that they can be rapidly silenced
upon receiving a signal to differentiate. Likewise, genes involved
in embryonic development must be silent, with the potential for
rapid activation.
The chromatin status of ESCs reflects their unique physiologic
needs. ESCs have a significant number of genes that are charac-
terized by very specific and unique histone and DNA modifica-
tions and are enriched for essential genes in early embryonic
development and developmental regulatory transcription factors
(Meissner, 2010). The promoters of these genes are character-
ized by the simultaneous presence, under certain growth
conditions, of histone modifications with seemingly opposite
functions. Individual nucleosomes at these promoters exhibit tri-
methylation of two different residues of histone H3: lysine 4
(H3K4me3) and lysine 27 (H3K27me3). While H3K4me3 is
enriched at promoters of actively transcribing genes or genes
with the potential for active transcription, H3K27me3 is associ-
ated with stable gene silencing. Loci at which these two histone
marks are juxtaposed on the same nucleosome are referred to as
bivalent (Meissner, 2010). Bivalent genes are generally transcrip-
tionally silent in ESCs but are poised for rapid activation
in the appropriate lineages during embryonic development.
In addition, these bivalent promoters are characterized by the
presence of a newly described form of DNA modification,
5-hydroxymethyl cytosine. How the enzymes that deposit these
chromatin marks interact with the core pluripotency network to
regulate the balance between self-renewal and differentiation
remains a central puzzle in ESC biology. A recent set of papers
(Reynolds et al., 2012a; Whyte et al., 2012; Yildirim et al., 2011)
has provided fresh insights into mechanisms underlying the
regulation of the pluripotency program and its response to devel-
opmental cues, indicating a central role for the nucleosome
remodeling and deacetylase (NuRD) complex in this compli-
cated regulatory process.
The NuRD chromatin remodeling complex was defined bio-
chemically more than a decade ago (Ramı´rez and Hagman,
2009). At the time of its discovery, this complex was unique in
that it possessed two distinct enzymatic functions directed
at chromatin-dependent gene regulation—histone deacetylasefunction from the HDAC1 and HDAC2 subunits and ATP-depen-
dent chromatin remodeling, a property of the Mi-2a/b subunits.
Further, NuRD contains a member of the methyl-CpG binding
domain family of proteins, MBD3, although mammalian MBD3
lacks the capacity to bind methylated DNA substrates with
high affinity. At the time of its discovery more than a decade
ago, prevailingmodels predicted that this complex was recruited
to promoters through direct interactions with DNA sequence-
specific transcriptional repressors where its enzymatic func-
tions—histone deacetylation and chromatin remodeling—were
integral to the process of stable gene silencing (Ramı´rez and
Hagman, 2009). This classic, static model for NuRD function is
now called into question by a very recent set of papers
describing a much more dynamic role for NuRD in maintenance
of gene activity in ESCs (Reynolds et al., 2012a; Whyte et al.,
2012; Yildirim et al., 2011).
NuRD and Polycomb Group Genes Antagonize LIF/Stat3
Signaling in ESC Differentiation
Elegant genetic analysis by Hendrich and colleagues defined an
essential role for MBD3 in integrity of the NuRD complex in
murine ESCs (MBD3 null ESCs fail to form functional NuRD
complex) and, surprisingly, demonstrated that deletion of
MBD3 and disruption of the NuRD complex did not significantly
impact ESC self-renewal (Kaji et al., 2006). However, MBD3
deletion led to defects in morphological changes, downregula-
tion of ESC markers, and upregulation of lineage markers upon
LIF withdrawal or during embryoid body formation, indicating
that the NuRD complex is required for normal differentiation.
In vivo, MBD3 null ESCs fail to make significant contributions
to chimeric embryos and can block the ability of wild-type
morulae to form functional embryos.
One possible mechanism by which the NuRD complex can
regulate differentiation is through the proper silencing of pluripo-
tency genes. In this issue of Cell Stem Cell, Reynolds et al.
(2012a) demonstrated using genetically manipulated ESCs that
loss of MBD3 leads to aberrant upregulation of genes integral
to the pluripotency network (including Zfp42, Tbx3, Klf4, and
Klf5) under normal growth conditions (Figure 1A), although
expression of the core pluripotency transcription factors Oct4,
Sox2, and Nanog are not affected. MBD3 deletion resulted in
their sustained expression upon LIF withdrawal, and knocking
down one of them, Klf4, could partially rescue the differentiation
defects. Chromatin immunoprecipitation visualized by quantita-
tive PCR demonstrated that MBD3 and Mi-2b both occupy theCell Stem Cell 10, May 4, 2012 ª2012 Elsevier Inc. 497
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Figure 1. NuRD Complex Opposes Histone
Acetyltransferases in Dynamic Regulation
of the ESC Transcriptional Program
(A) A dynamic model for NuRD complex function
based on the work from Hendrich and colleagues
(Reynolds et al., 2012a, 2012b). At genes integral
to the pluripotency program, histone acetyl-
transferase (HAT) enzymes function as chromatin
regulators promoting gene activity. NuRD
complex, through its histone deacetylase subunits
(HDAC), opposes their function and serves to
dampen expression. Balance between the acti-
vating functions of HAT enzymes and the repres-
sive HDAC activity of NuRD fine-tunes expression
of these genes. At bivalent genes that are poised
for activation during embryonic development,
the HDAC functions of NuRD are required for
stable association of PRC2 and maintenance of
H3K27me3.
(B) In the work of Whyte et al. (2012), NuRD
complex HDAC activity acts in competition with
p300 or other HAT enzymes at active enhancers in
pluripotent cells to maintain a balance of histone
acetylation under normal ESC growth conditions.
Under conditions favoring differentiation, NuRD
deacetylates histone H3K9, making this histone
a substrate for LSD1 to demethylate H3K4, a
necessary step in turning off an enhancer occu-
pied by the core pluripotency network. Loss of
enhancer activity results in downregulation of
transcription and, ultimately, in gene silencing.
(C) Yildirim et al. (2011) depict NuRD complex in
competition with the esBAF complex at highly
transcribed genes, including genes downstreamof
LIF-Stat signaling. These two chromatin regulators
act in an opposing fashion to regulate nucleosome
occupancy through the ATPase subunits BRG1
(esBAF) and Mi-2b (NuRD). The balance of these
activities at core promoters serves to fine-tune
RNA polymerase recruitment.
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a broad pattern stretching across several kilobases of DNA (Fig-
ure 2B). These findings are consistent with the LIF-independent
ESCmaintenance phenotype observed in theMBD3 null cells, as
Tbx3, Klf4, and Klf5 act downstream in the LIF-Stat3 pathway
(Niwa et al., 2009).
It was previously known that the expression of Zfp42, Tbx3,
Klf4, and Klf5 is heterogeneous in ESCs cultured in serum and
LIF (Toyooka et al., 2008) and that there are subpopulations of
cells expressing low or high levels of these proteins. In the
absence of MBD3, however, the low-expressing cell population
disappeared and all the cells express higher levels, suggesting
that NuRD is responsible for the repression of these genes during
normal ESC culture (Reynolds et al., 2012a). These findings
support a model in which a balance between transcriptional acti-
vation from the LIF-Stat3 pathway and repression from the NuRD
complex is in dynamic equilibrium at a subset of pluripotency
genes in ESCs (Figure 1A) resulting in the observed transcrip-
tional heterogeneity. By extension, NuRD-mediated repression498 Cell Stem Cell 10, May 4, 2012 ª2012 Elsevier Inc.of these same pluripotency genes is
probably a necessary step for differentia-
tion. It is important to note that NuRD-
mediated repression does not operate
to silence all pluripotency genes. For
example, MBD3 deletion does not impactexpression of the core pluripotency transcription factors Nanog,
Oct4, and Sox2 (Reynolds et al., 2012a). Additionally, Nanog is
also known to be expressed in a heterogeneous fashion in
ESCs cultured in serum and LIF (Chambers et al., 2007). Its
expression is controlled by an allelic regulatory mechanism inde-
pendent of DNAmethylation (Miyanari and Torres-Padilla, 2012).
In another very recent study from the same group, an impor-
tant relationship was established between NuRD and another
chromatin modifying complex, PRC2 (Reynolds et al., 2012b).
PRC2, polycomb repressive complex 2, is responsible for the
repressive histonemark H3K27me3, which is deposited on chro-
matin by its subunit EZH2 (Meissner, 2010). NuRD was shown to
occupy genomic loci corresponding to genes marked by H3K4
trimethylation as well as bivalent genes in ESCs andmay thereby
modulate actively transcribed genes as well as those marked by
bivalent chromatin for eventual expression at a later point in
development. MBD3 deletion led to an increase in H3K27 acet-
ylation and a loss of H3K27 trimethylation at the bivalent NuRD
target genes, suggesting a concerted action between NuRD
AB
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Figure 2. NuRDComplex Action andDistribution in
the ESC Genome
(A) Fazzio and colleagues provide evidence suggesting
that NuRD complex localizes to specific regions of the
genome through direct interaction of MBD3 with 5hmC
modified DNA, a mark deposited by TET1 (Yildirim et al.,
2011).
(B) ChIP PCR (Reynolds et al., 2012a) and ChIP-Seq
(Reynolds et al., 2012b) depict (yellow shaded areas)
broad distribution of NuRD complex across kilobases of
DNA surrounding the TSS of pluripotency genes. Note that
this model depicts a gap in NuRD complex enrichment
over the TSS. ChIP-Seq (Yildirim et al., 2011) determina-
tion of focal localization of NuRD complex in ESCs is
shown (yellow shaded areas). Strongest peaks were
detected slightly downstream of the TSS, little to no
enrichment was noted at enhancers. ChIP-Seq (Whyte
et al., 2012) of NuRD complex in ESCs (yellow shaded
areas) in focal areas of enrichment coincident with both
enhancers and core promoters is shown. Enrichment at
enhancers was noted in peaks larger than those detected
near the TSS.
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PRC2, which methylates lysine 27—at these sites (Figure 1A).
Indeed, MBD3 deletion or HDAC inhibition impaired the binding
of PRC2 components to some of the NuRD target genes. On the
contrary, deletion of PRC2 components did not affect binding
of the NuRD complex to its target genes. Thus, recruitment of
PRC2 at NuRD target loci is dependent on the presence
and activity of NuRD. Consistently, deletion or knockdown of
MBD3 or components of the PRC complexes induced overlap-
ping gene expression changes, including the upregulation of
several genes involved in embryonic development (Reynolds
et al., 2012b).
Taken together, the above findings supported the following
model for NuRD’s function in ESC differentiation (Figure 1A):
MBD3/NuRD deacetylates histone lysine residues (including
H3K27) at genes involved in embryonic development or pluripo-
tency. At some genes (those downstream of LIF or of the core
pluripotency network), the continued action of histone acetyl-
transferase (HAT) enzymes rapidly resets acetylation state,
resulting in an equilibrium favoring active transcription. At other
genes (genes involved in embryonic development), the hypoace-
tylated state at lysine 27 resulting from NuRD-dependent
deacetylation is permissive for PRC2 recruitment, H3K27 trime-
thylation, and transcriptional repression. Thus, NuRD-mediated
deacetylation serves as a brake to fine-tune the expression of
pluripotency genes and provides a mechanism for maintenance
of genes involved in embryonic development in a poised or silent
state. In agreement with this model, PRC2 has been shown
to play important roles in ESC differentiation. Loss of PRC2
function in ESCs results in mis-regulation of pluripotency and
developmental genes and defects in differentiation (Table 1).Cell SThe genetic functional data presented by
these two papers provides an attractive model
to explain important aspects of the role of
NuRD in the pluripotency program. It should
be noted that, like all models, this one does
not explain all the existing data. In particular,
analysis of animals and cells genetically engi-
neered at PRC2 genes suggests that the storymay not be entirely this simple (Table 1). Animals null for the
PRC2 components Suz12, Eed, and Ezh2 show developmental
defects at slightly later stages than animals lacking MBD3. In
these models, development fails around or after the time of
gastrulation, suggesting that these animals have some capacity
for differentiation. In ESCs, PRC2 deficiency can lead to a much
less severe block on differentiation than loss ofMBD3, as Eed or
Suz12 null ESCs can still form embryoid bodies, and in some
cases differentiate into three germ layers and contribute to
chimeras (Table 1). These data suggest that a model with
NuRD acting solely as a mediator for PRC2-induced repression
does not explain all the requirements for NuRD in this process.
Maintaining Pluripotency by Repression of Pluripotency
Genes
Repression of pluripotency genes is required for differentiation.
Whyte et al. recently reported that LSD1, a histone H3K4/K9
demethylase, is required for ESC differentiation by decommis-
sioning, or silencing, ESC-specific enhancers (Whyte et al.,
2012). They found that inhibition of LSD1 in ESCs through RNA
interference or pharmacologic methods prevented the normal
silencing of pluripotency genes such as Nanog and Sox2 under
differentiation conditions, without affecting the upregulation of
lineage markers. A genome-wide ChIP approach demonstrated
that LSD1 occupies the enhancers and promoters of roughly
90% of actively transcribed and 2/3 of bivalent genes. Occu-
pancy was noted at both promoter and enhancer regions, with
peaks being higher at enhancer regions (Figure 2B). Focusing
their attention on enhancer elements occupied by the core
pluripotency transcription factors Oct4, Nanog, and Sox2, the
authors found that inhibition of LSD1 blocked the removal oftem Cell 10, May 4, 2012 ª2012 Elsevier Inc. 499
Table 1. Null Phenotypes of NuRD, PRC2, and Other Chromatin Regulators
Complex Gene ES phenotype Mouse phenotype Reference
NuRD MBD3 Mbd3 null ESCs are viable and can
initiate differentiation in embryoid
bodies or chimeric embryos but cannot
completely silence pluripotency genes
or commit to developmental lineages.
Mbd3 null mice die around midgestation.
Null embryos have defective epiblast
expansion and extraembryonic tissue
development starting at E5.5.
Kaji et al., 2006, 2007
PRC2 Eed Eed null ESCs are viable and can
differentiate in embryoid bodies. They
can contribute to chimeras (up to E9.5),
but their in vitro differentiation capacity is
impaired.
Eed null mice are embryonic lethal by
E9.5. Null embryos exhibit growth
defects and primitive streak formation
and/or organization.
Chamberlain et al., 2008;
Leeb et al., 2010
Ezh2 Ezh2 null ESCs can self-renew and
differentiate. They have impaired
differentiation capacity, but not to the
extent seen in Eed null ESCs.
Ezh2 null mice arre embryonic lethal before
E8.5. Null embryos can initiate but cannot
complete gastrulation.
O’Carroll et al., 2001;
Shen et al., 2008
Suz12 Suz12 null cells are viable but have
impaired differentiation capacity.
Suz12 null mice are embryonic lethal
between E8.5 to 10.5. Null embryos
show gastrulation defects that induce
a developmental block around E7.5.
Pasini et al., 2007
Tet1 Tet1 Tet1 null ESCs have reduced 5hmC
level and subtle changes in gene
expression. They can self-renew
and are pluripotent with skewed
differentiation toward trophectoderm
in vitro.
Tet1 null mice are viable, fertile, and grossly
normal, though some have a slightly smaller
body size at birth.
Dawlaty et al., 2011
esBAF Brg1 Brg1-null ESCs show defects in
self-renewal and pluripotency.
Brg1 null mice are embryonic lethal
at the peri-implantation stage.
Bultman et al., 2000;
Ho et al., 2011
LSD1 LSD1 Lsd1 null ESCs have growth defects,
cannot form embryoid bodies, and
cannot properly silence ESC genes
during differentiation.
Lsd1 null mice are embryonic lethal before
E7.5 with arrested embryonic development
at or before E5.5. The egg cylinder failed to
elongate and undergo gastrulation.
Wang et al., 2007, 2009a;
Whyte et al., 2012
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tion. Thus, LSD1 demethylates H3K4me1 at ESC-specific
enhancers during differentiation to facilitate repression of pluripo-
tency genes, defining LSD1 as essential for decommissioning
enhancers. Partially consistent with these findings, another study
in human ESCs also found that LSD1-bound genes are highly en-
riched for thosewithbivalentdomainsand thoseoccupiedbyOct4
andNanog (Adamoetal., 2011).However, in thiscaseLSD1and its
demethylase activity were required to maintain ESC self-renewal
and suppress differentiation into mesoendodermal lineages,
possibly by reducing H3K4 methylation at its target promoters.
The precise reason(s) for these discrepancies remain unclear,
although human and murine ESCs do represent different pluripo-
tent stem cells and require different mechanisms for self-renewal.
Interestingly, Whyte et al. showed that LSD1 physically inter-
acts with and co-occupies enhancer regions with the NuRD
complex in ESCs (of approximately 5500 genes bound by
Mi-2b, 4800 are also bound by LSD1), suggesting that LSD1
and NuRD have broad functional overlap (Whyte et al., 2012).
Consistent with that idea, biochemical and genomic association
between LSD1 and NuRD had been previously described, albeit
in a different biological context (Wang et al., 2009b). The authors
proposed that NuRD complex and LSD1 function together at
these enhancers to alter the local chromatin status and suppress
enhancer function during the differentiation process (Figure 1B).
Depletion of the core NuRD ATPase subunit, Mi2-b, resulted in500 Cell Stem Cell 10, May 4, 2012 ª2012 Elsevier Inc.defects in ESC differentiation in vitro and failure to downregulate
a set of pluripotency genes in a manner very similar to loss of
LSD1 function. Mechanistically, the authors invoke the enzy-
matic properties of LSD1 to explain its reliance on NuRD
function—the enzyme has greatly reduced affinity for peptide
substrates containing acetylation at lysine 9 of histone H3
(Forneris et al., 2005). Somewhat surprisingly, Whyte et al.
(2012) fail to find significant colocalization of LSD1with CoREST/
REST proteins, which have been previously tightly linked
physically and functionally to LSD1 in other systems (Lee et al.,
2005), including human ESCs (Adamo et al., 2011).
A common theme emerges from the above studies of
NuRD, PRC2, and LSD1: dynamic equilibria between various
histone modification enzymes results in a plastic regulatory
state under the control of the core pluripotency transcription
factor network as well as the signaling pathways known to
contribute to ESC pluripotency. Action of the core pluripotency
transcription factors and signaling pathways opposes the
repressive functions of NuRD and LSD1, ensuring continued
expression. LIF withdrawal (or other physiologic cues) results
in loss of positive signals, upon which the repressive functions
of NuRD and LSD1 dominate, permitting normal differentiation
(Figures 1A and 1B). In the absence of these critical repressive
factors, proper fine-tuning is lost at many genes and the
ability to downregulate the pluripotency network is severely
compromised. This delicate balance of opposing chromatin
Cell Stem Cell
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ensure developmental plasticity while maintaining the ability to
self-renew.
Integration of the Activating and Repressive Signals
The LIF-Stat3 pathway constitutes a positive signal balancing
the negative regulation of pluripotency genes by the NuRD and
PRC2complexes.Crabtreeandcolleagues recentlydemonstrated
that LIF-Stat3 signaling in ESCs is partly dependent on Brg1 (Ho
etal., 2011), theATPasesubunit of a specializedchromatin remod-
eling complex in ESCs termed esBAF. Brg1 is required for main-
taining the binding of Stat3 and preventing PRC2-mediated
H3K27me3 at some Stat3 target sites. LIF withdrawal and Brg1
deletion induced similar gene expression changes that could be
rescued through deletion of the PRC2 component Suz12. These
results suggested that Brg1 helps to propagate the LIF/Stat3
signaling axis in part through blocking the action of PRC2—and
thus acting in a yin/yang fashion with NuRD.
More recently, Fazzio and colleagues found that MBD3
silencing by RNAi led to gene expression changes that are
largely opposite to those caused by Brg1 silencing, and double
knockdown of Brg1 and MBD3 resulted in a more wild-type
expression profile (Yildirim et al., 2011). Furthermore, MBD3
and Brg1 interact with each other biochemically and co-occupy
many gene promoter regions where they antagonistically control
nucleosome occupancy and regulate recruitment of RNA
polymerase II. Surprisingly, normal localization of MBD3 was
completely lost in cells depleted for Brg1, suggesting some
physical or functional requirement for esBAF function in NuRD
localization. Together, these results indicated that the repressive
signals from the NuRD and PRC2 complexes and the activation
signals from LIF-Stat3 and Brg1 function in opposition to fine-
tune the expression of genes required for ESC self-renewal
(Figure 1C). Analyses of genetically manipulated mice (Table 1)
also indicate that loss of either MBD3 or Brg1 results in early
failure of development at the peri-implantation stage.
Indeed, the interplay between LIF-Stat3 and NuRD contrib-
uted to the heterogeneous expression of pluripotency genes
such as Zfp42, Tbx3, Klf4, and Klf5 in ESCs as described by
Hendrich and colleagues. As mentioned above, these genes
are normally expressed at low or high levels in subpopulations
of ESCs grown in serum and LIF medium. LIF withdrawal led to
the collapse of the subpopulations into one low-expressing pop-
ulation, while MBD3 deletion generated one high-expressing
population. Interestingly, NuRD protein levels and its occupancy
at target gene promoters do not change between subpopula-
tions of ESCs that express high or low levels of the pluripotency
gene Zfp42. On the contrary, Stat3 activity was found to be
higher in Zfp42-high cells, suggesting that LIF-Stat3, but not
NuRD, is the rate-limiting factor for pluripotency gene expres-
sion. Taken together, these data suggest that LIF-dependent
self-renewal results in part from the action of Brg1 in opposing
the repressive functions of NuRD and PRC2 at Stat3 target loci.
NuRD Recruitment to Target Sites in the Genome
A critical question unaddressed to this point is how are
promoters/enhancers selected for local enrichment of NuRD,
LSD1, or other chromatin modification enzymes? Considerable
evidence suggests sequence-dependent recruitment of poly-comb complexes in flies, and similar recruitment sequences
may also exist in mammals (Woo et al., 2010). Crabtree and
colleagues suggested transcription factor-dependent recruit-
ment of Brg1 by Stat3 (Ho et al., 2011). What about NuRD? Is
the complex uniquely recruited to focal regions by specific inter-
actions or does it act in a more broad sense across large regions
of the genome? An interesting analysis by Yildirim et al. indicated
that the genomic binding patterns of MBD3 as measured by
ChIP-Seq strongly overlapped with that of Tet1 (Figure 2A), an
enzyme that catalyzes the oxidation of 5-methylcytosine (5mC)
to 5-hydroxymethylcytosine (5hmC), and MBD3 was completely
delocalized in Tet1 knockdown cells (Yildirim et al., 2011). In
a biochemical assay, MBD3/NuRD complex could bind to both
unmodified and hydroxymethylated DNA substrates, suggesting
that 5hmC may recruit MBD3/NuRD to 5hmC-marked genes.
While attractive at first glance, it is unclear how consistent this
model may be with the existing literature. First, the biological
data appear, at best, unresolved. The role of Tet1 or 5hmC in
ESCs remains controversial (Freudenberg et al., 2011). A role
for either in self-renewal has not been fully established, and
Tet1 deletion or silencing by RNAi has not been associated, to
date, with defects in differentiation (reviewed in Wu and Zhang,
2011). Second, recent biophysical analysis by Xiaodong Cheng
and colleagues indicates that MBD3 binds double-stranded
DNA with a micromolar dissociation constant and has no signif-
icant difference in affinity when comparing unmodified to 5hmC
modified substrates of identical sequence (Hashimoto et al.,
2012). Finally, Hendrich and colleagues have elegantly demon-
strated genetic complementation of MBD3 KO ESCs using the
MBD3b isoform—a splice variant that disrupts the primary
sequence (and probably destroys normal structure) of themethyl
CpG binding domain (Reynolds et al., 2012a, 2012b). In a similar
vein, the genetics and biochemistry of Tet1 and NuRD seem
contradictory. Yildrim et al. (2011) report that depletion of Tet1
in ESCs results in a complete loss of NuRD localization at all
promoters examined, despite normal levels of MBD3 protein in
these cells. This finding is difficult to understand given the recent
report that Tet1 null animals survive to birth and appear normal
(Dawlaty et al., 2011). Thus, elucidation of mechanisms for
recruitment of NuRD to promoters/enhancers may not have
reached the point of consensus.
Is It Really All So Simple?
Collectively, the recent papers reviewed here have added
considerable depth to the literature linking NuRD complex to
the ESC transcriptional program. These papers support a model
wherein a complicated balance between positive and negative
forces dictates transcriptional output at genes integral to
self-renewal and development. Despite being performed with
different goals and using diverse methods, these experiments
display considerable convergence in outcomes and conclusions.
In stark contrast to the big-picture conclusions, there are
striking areas in which these papers simply do not agree on
matters of critical importance. Principal among them is the
precise localization pattern of NuRD in ESCs. Reynolds et al.
(2012a, 2012b) describe localization ofMi-2b andMBD3 in broad
regions of several kilobases containing promoters and gene
bodies (Figure 2B). It is evident in their data that NuRD complex
peaks both upstream and downstream of a pronounced dip atCell Stem Cell 10, May 4, 2012 ª2012 Elsevier Inc. 501
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Minireviewthe transcription start site (TSS). In contrast, both the Yildirim
et al. (2011) and Whyte et al. (2012) papers depict focal accumu-
lation at core promoters. Fazzio and colleagues provide further
definition, stipulating the presence of a prominent peak of
NuRD immediately downstream from the TSS (Yildirim et al.,
2011). These authors posit that MBD3 localizes primarily to
promoters with little association seen at enhancers (Figure 2B).
This contrasts with the study byWhyte et al. (2012) who describe
NuRD localization at roughly 2,500 known enhancers (Figure 2B).
How do we reconcile these differences? All three groups report
results with compromised signal-to-noise ratios and/or inex-
haustive coverage. Reynolds et al. (2012a, 2012b) and Yildirim
et al. (2011) report similar results for multiple antibodies targeting
MBD3 and/or Mi-2b, making it unlikely that the differences
observed result from use of vastly different reagents. In the
absence of any glaringly obvious explanations, we are left with
the unsatisfying probability that the problem could be technical.
Chromatin regulators are notoriously difficult to ChIP produc-
tively (Ram et al., 2011). These complexes are generally large,
their proximity to DNA may be an issue (standard formaldehyde
cross-linking has an effective radius of only 1.9 A˚), their chem-
istrymay impair effective cross-linking (formaldehyde cross-link-
ing occurs through lysine residues), and their residence time on
chromatin is generally unknown. Alternatively, given the large
data sets involved, each group may have chosen to focus on
one particular aspect of the data. Analysis of each data set in
an identical manner by independent analysts may provide addi-
tional insight into the differences/commonalities between the
actual data. Whatever the reasons, technical or otherwise,
underlying the differences in results reported by these three
groups, the issue of precisely where NuRD complex is distrib-
uted relative to genes will require additional work.
Summary and Perspectives
Since its initial biochemical discovery, the NuRD complex has
been predicted to contribute to stable gene silencing through
the enzymatic actions of histone deacetylation and chromatin re-
modeling. While useful at the time of its inception, it has become
increasingly clear that such a model cannot explain all the data.
Of particular note, beautiful genetic studies by Georgopoulos
and colleagues have provided clear in vivo evidence for roles
for NuRD complex in gene activation as well as repression in
lymphocytes (Zhang et al., 2012). The current set of new manu-
scripts carry this concept further. Collectively, they depict genes
integral to self-renewal and genes critical to early embryonic
development as regulatory targets of the NuRD complex. In all
cases (Figure 1), normal homeostasis results from a delicate
balance between the repressive functions of NuRD (along with
its functional partners PRC2 and/or LSD1) in opposition to acti-
vating functions of transcription factors (Stat3 or Oct4), histone
acetyltransferases (p300), and other chromatin remodeling
complexes (esBAF). Themodel is simple, and it greatly advances
our concept of how ESCs maintain the exquisite plasticity
of gene expression necessary to support development while
retaining the ability to self-renew.
Like all models, this one does not explain all the data and will
ultimately be proven wrong in at least some aspects. It remains
unclear the reason why specifics regarding localization of NuRD
differ so much in the various studies. Likewise, the mode of502 Cell Stem Cell 10, May 4, 2012 ª2012 Elsevier Inc.recruitment of NuRD to genes—whether it is ultimately agreed
that it is focal, it is broadly distributed, or the pattern depends
onwhich gene is analyzed—remains poorly understood. Further-
more, themechanisms bywhich cells overcome the combination
of NuRD and PRC2 at genes integral to early embryonic develop-
ment are not understood in any degree of detail. Regardless of
the limitations, this new model prompts a re-examination of
how NuRD functions and will undoubtedly inspire a new genera-
tion of studies that will further dissect the interplay of transcrip-
tion factors, signaling pathways, and chromatin regulators in
the unique biology of ESCs.
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